Target intelligence / Profile preview

Sickle-induced non-selective cation pathway (Psickle) (Psickle)

Target
Psickle
Molecular classification
Ion channel, Membrane transport system
01

Overview

The sickle-induced cation leak pathway, commonly referred to as "Psickle", is a deoxygenation-induced, non-selective cation conductance found in the red blood cells of individuals with sickle cell disease (Lew & Bookchin, 2005). Upon deoxygenation, the polymerization of hemoglobin S (HbS) causes mechanical stress on the erythrocyte membrane, activating this pathway and allowing the influx of calcium and sodium and the efflux of potassium (Tiffert et al., 2003). The resulting increase in intracellular calcium activates the Gardos channel (KCNN4), leading to rapid loss of potassium and water, which causes cell dehydration, increases HbS concentration, and accelerates further sickling (Vandorpe et al., 2011). This pathway is a critical therapeutic target because its inhibition can prevent the cycle of dehydration and sickling that leads to vaso-occlusive crises and hemolysis. Recent evidence suggests that the mechanosensitive ion channel Piezo1 may be a primary molecular component of the Psickle conductance (Cahalan et al., 2015). Pharmacological interventions, such as the Gardos channel inhibitor Senicapoc or experimental Piezo1 inhibitors like GsMTx4, aim to block this leak or its downstream effects to maintain red cell hydration and reduce the severity of sickle cell disease symptoms (Ataga et al., 2008).

Other names
PsickleDeoxygenation-induced cation conductanceSickle erythrocyte cation leakHbS-induced cation flux
02

Mechanism of action

Inhibition of deoxygenation-induced cation permeability to prevent erythrocyte dehydration and subsequent hemoglobin S polymerization.

03

Biological functions

Ion homeostasisCell volume regulationErythrocyte hydration
04

Disease associations

Sickle cell diseaseHemolytic anemia
05

Safety considerations

Off-target inhibition of mechanosensitive channels in other tissuesPotential disruption of normal erythroid volume regulationClinical dissociation between improved hydration and reduction in vaso-occlusive crises
06

Interacting drugs

Senicapoc

4 more in the full profile.

07

Biomarkers

Erythrocyte densityMean corpuscular hemoglobin concentration (MCHC)Percentage of irreversibly sickled cells

Beyond the preview

Go deeper on Sickle-induced non-selective cation pathway (Psickle) (Psickle).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sickle-induced non-selective cation pathway (Psickle) (Psickle).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call